Last10K.com

Novo Nordisk A S (NVO) SEC Filing 20-F Annual Report for the fiscal year ending Saturday, December 31, 2022

SEC Filings

NVO Annual Reports

Novo Nordisk A S

CIK: 943605 Ticker: NVO

View differences made from one year to another to evaluate Novo Nordisk A S's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Novo Nordisk A S.

Continue

Assess how Novo Nordisk A S's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Novo Nordisk A S's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Audit Information
Cover
Balance Sheet
Cash Flow Statement
Equity Statement
Income Statement And Statement Of Comprehensive Income
Income Statement And Statement Of Comprehensive Income - Statement Of Comprehensive Income
Basis Of Preparation
Basis Of Preparation (Policies)
Capital Structure And Financial Items
Capital Structure And Financial Items (Tables)
Capital Structure And Financial Items - Borrowings - Contractual Undiscounted Cash Flows (Details)
Capital Structure And Financial Items - Borrowings - Issuance Of Eurobonds (Details)
Capital Structure And Financial Items - Borrowings - Narrative (Details)
Capital Structure And Financial Items - Borrowings - Reconciliation Of Liabilities Arising From Financing Activities (Details)
Capital Structure And Financial Items - Cash And Cash Equivalents And Free Cash Flow - Cash And Cash Equivalents (Details)
Capital Structure And Financial Items - Cash And Cash Equivalents And Free Cash Flow - Narrative (Details)
Capital Structure And Financial Items - Change In Working Capital - Change In Working Capital (Details)
Capital Structure And Financial Items - Derivative Financial Instruments - Derivative Financial Instruments (Details)
Capital Structure And Financial Items - Derivative Financial Instruments - Narrative (Details)
Capital Structure And Financial Items - Distributions To Shareholders - Narrative (Details)
Capital Structure And Financial Items - Financial Assets And Liabilities - Fair Value Measurement Hierarchy (Details)
Capital Structure And Financial Items - Financial Assets And Liabilities - Financial Assets By Category (Details)
Capital Structure And Financial Items - Financial Assets And Liabilities - Financial Liabilities By Category (Details)
Capital Structure And Financial Items - Financial Income And Expenses - Financial Expenses (Details)
Capital Structure And Financial Items - Financial Income And Expenses - Financial Impact From Forward Contracts (Details)
Capital Structure And Financial Items - Financial Income And Expenses - Financial Income (Details)
Capital Structure And Financial Items - Financial Risks - Cash And Cash Equivalents And Financial Reserves (Details)
Capital Structure And Financial Items - Financial Risks - Credit Exposure For Cash At Bank, Marketable Securities And Derivative Financial Instruments (Details)
Capital Structure And Financial Items - Financial Risks - Derecognised Receivables (Details)
Capital Structure And Financial Items - Financial Risks - Financial Contracts (Details)
Capital Structure And Financial Items - Financial Risks - Foreign Exchange Sensitivity Analysis (Details)
Capital Structure And Financial Items - Financial Risks - Key Currencies (Details)
Capital Structure And Financial Items - Financial Risks - Narrative (Details)
Capital Structure And Financial Items - Other Non-Cash Items - Other Non-Cash Items (Details)
Capital Structure And Financial Items - Share Capital, Treasury Shares And Other Reserves - Narrative (Details)
Capital Structure And Financial Items - Share Capital, Treasury Shares And Other Reserves - Share Capital (Details)
Capital Structure And Financial Items - Share Capital, Treasury Shares And Other Reserves - Specification Of Other Reserves (Details)
Capital Structure And Financial Items - Share Capital, Treasury Shares And Other Reserves - Treasury Shares (Details)
Capital Structure And Financial Items -Distributions To Shareholders - Distribution To Shareholders (Details)
Operating Assets And Liabilities
Operating Assets And Liabilities (Tables)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Intangible Assets - Amortisation And Impairment Losses (Details)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Intangible Assets - Narrative (Details)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Intangible Assets And Property, Plant And Equipment (Details)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Intangible Assets And Property, Plant And Equipment - Narrative (Details)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Property, Plant And Equipment - Depreciation And Impairment Losses (Details)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Property, Plant And Equipment - Narrative (Details)
Operating Assets And Liabilities - Inventories - Inventories (Details)
Operating Assets And Liabilities - Leases - Leased Property, Plant And Equipment (Details)
Operating Assets And Liabilities - Leases - Narrative (Details)
Operating Assets And Liabilities - Provisions And Contingent Liabilities - Narrative (Details)
Operating Assets And Liabilities - Provisions And Contingent Liabilities - Provisions (Details)
Operating Assets And Liabilities - Trade Receivables - Trade Receivables (Details)
Other Disclosures
Other Disclosures (Tables)
Other Disclosures - Acquisition Of Businesses - Fair Value Of Recognized Assets And Liabilities (Details)
Other Disclosures - Acquisition Of Businesses - Narrative (Details)
Other Disclosures - Commitments - Contractual Obligations Not Recognised In The Balance Sheet (Details)
Other Disclosures - Commitments - Narrative (Details)
Other Disclosures - Companies In The Novo Nordisk Group (Details)
Other Disclosures - Fee To Statutory Auditors - Fee To Statutory Auditors (Details)
Other Disclosures - Related Party Transactions - Material Transactions With Related Parties (Details)
Other Disclosures - Related Party Transactions - Narrative (Details)
Other Disclosures - Share-Based Payment Schemes - General Terms And Conditions Of Launched Programmes (Details)
Other Disclosures - Share-Based Payment Schemes - Long-Term Share-Based Incentive Programme - Narrative (Details)
Other Disclosures - Share-Based Payment Schemes - Outstanding Restricted Stock Units (Details)
Other Disclosures - Share-Based Payment Schemes - Restricted Stock Units To Employees - Narrative (Details)
Other Disclosures - Share-Based Payment Schemes - Share-Based Payment Expensed In The Income Statement (Details)
Results For The Year
Results For The Year (Tables)
Results For The Year - Earnings Per Share (Details)
Results For The Year - Employee Costs - Employee Costs (Details)
Results For The Year - Employee Costs - Remuneration To Executive Management And Board Of Directors (Details)
Results For The Year - Income Taxes And Deferred Income Taxes - Computation Of Effective Tax Rate (Details)
Results For The Year - Income Taxes And Deferred Income Taxes - Development In Deferred Income Tax Assets And Liabilities (Details)
Results For The Year - Income Taxes And Deferred Income Taxes - Income Taxes Expensed (Details)
Results For The Year - Income Taxes And Deferred Income Taxes - Income Taxes Paid (Details)
Results For The Year - Income Taxes And Deferred Income Taxes - Narrative (Details)
Results For The Year - Net Sales And Rebates - Gross-To-Net Sales Reconciliation (Details)
Results For The Year - Net Sales And Rebates - Narrative (Details)
Results For The Year - Research And Development Costs - Research And Development Costs (Details)
Results For The Year - Segment Information - Business Segments - Key Figures (Details)
Results For The Year - Segment Information - Narrative (Details)
Results For The Year - Segment Information - Net Sales - Business Segments And Geographical Areas (Details)
Ticker: NVO
CIK: 353278
Form Type: 20-F Annual Report
Accession Number: 0001628280-23-001868
Submitted to the SEC: Wed Feb 01 2023 7:53:07 AM EST
Accepted by the SEC: Wed Feb 01 2023
Period: Saturday, December 31, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/nvo/0001628280-23-001868.htm